Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

39.10p
   
  • Change Today:
      1.10p
  • 52 Week High: 62.00
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 690,401
  • Market Cap: £211.30m
  • RiskGrade: 119

Alliance Pharma appoints Andrew Franklin as finance director

By Michele Maatouk

Date: Friday 10 Jul 2015

LONDON (ShareCast) - Specialty pharmaceutical company Alliance Pharma announced the appointment of Andrew Franklin as finance director with effect from 28 September 2015.
Franklin joins the company from Panasonic Europe, where he was general manager, European tax and accounting. Before that, he was finance director and company secretary of Genzyme Therapeutics from 2010 to 2012.

Chief executive officer John Dawson said: "We welcome Andrew to Alliance as our new finance director. He brings considerable experience, having operated for 14 years in senior financial roles in the pharmaceutical industry. Andrew will be a strong addition to the Alliance team."

At 10:30, shares were up 1.5% at 44.93p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 39.10p
Change Today 1.10p
% Change 2.89 %
52 Week High 62.00
52 Week Low 29.35
Volume 690,401
Shares Issued 540.40m
Market Cap £211.30m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.05% above the market average84.05% above the market average84.05% above the market average84.05% above the market average84.05% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
57.59% below the market average57.59% below the market average57.59% below the market average57.59% below the market average57.59% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
1.13% below the market average1.13% below the market average1.13% below the market average1.13% below the market average1.13% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
89% below the market average89% below the market average89% below the market average89% below the market average89% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 30-May-2024

Time Volume / Share Price
16:35 102,104 @ 39.10p
16:35 97 @ 39.10p
16:35 1,048 @ 39.10p
16:35 1,061 @ 39.10p
16:35 1,072 @ 39.10p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page